Picture of Curasight A/S logo

CURAS Curasight A/S News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeSmall CapMomentum Trap

Brief: Curasight A/S Says Positive Data Of Utreat In Glioblastoma Provides "Green Light" To Proceed With Next Steps

June 24 (Reuters) - Curasight A/S  CURAS.TE :
    * POSITIVE DATA OF UTREAT® IN GLIOBLASTOMA PROVIDES "GREEN
LIGHT"
TO PROCEED WITH NEXT STEPS
    * BIODISTRIBUTION RESULTS FROM CURASIGHT A/S' ("CURASIGHT")
TESTING OF UTREAT® FOR TREATMENT OF GLIOBLASTOMA ARE NOW
AVAILABLE
    * RESULTS ARE POSITIVE AND PROVIDE "GREEN LIGHT" TO PROCEED
TO
NEXT STEP
    * FIRST STEP IN TESTING NEW TARGETED RADIONUCLIDES IS STUDY
OF
BIODISTRIBUTION

Source text for Eikon:  ID:nWkr75RylP 
Further company coverage:  CURAS.TE 

 ((reuters.briefs@thomsonreuters.com;))

Recent news on Curasight A/S

See all news